Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by celine.gongora
Group name EquipeCG
Item Type Journal Article
Title Clinical Relevance of Routine Monitoring of Patient-reported Outcomes Versus Clinician-reported Outcomes in Oncology
Creator Fiteni et al.
Author Frederic Fiteni
Author Alice Cuenant
Author Mireille Favier
Author Christelle Cousin
Abstract The National Cancer Institute Common Terminology Criteria for Adverse Events classification is the standard classification used by the physicians in oncology for reporting adverse events. This classification has evolved over the last years according to the emergence of new therapies. Reporting symptoms, quality of life (QoL) and toxicities via patient-reported outcomes (PROs) in clinical practice is not yet a standard of care, nevertheless many studies have been conducted recently to assess feasibility and impact of routine monitoring of PROs, which should enable for better management of toxicities and earlier detection of disease progression in a more patient-centered health care delivery system. The aim of this article was to discuss the advantages and limitations of both approaches, clinicians-reported outcomes and PROs. Growing evidence supports that the routine collection of PROs leads to improvement of QoL and overall survival of cancer patients.
Publication In Vivo (Athens, Greece)
Volume 33
Issue 1
Pages 17-21
Date 2019 Jan-Feb
Journal Abbr In Vivo
Language eng
DOI 10.21873/invivo.11433
ISSN 1791-7549
Library Catalog PubMed
Extra PMID: 30587597 PMCID: PMC6364064
Tags clinicians-reported outcomes, electronic patient-reported outcomes, Humans, last, Neoplasms, Patient Reported Outcome Measures, Patient-reported outcomes, Physicians, Quality of Life, review, Treatment Outcome
Date Added 2019/05/14 - 12:04:54
Date Modified 2019/10/24 - 16:00:06
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés